2013 国际临床实践指南:癌症患者中心静脉导管血栓形成的治疗和预防

2013-01-01 国际血栓形成和癌症创议 J Thromb Haemost. 2013 Jan;11(1):71-80.

尽管长期留置中心静脉导管可能会导致肺栓塞,临床缺少癌症患者和异质性人群中心静脉导管相关血栓形成的管理共识,本文的主要目的就是针对该类患者中心静脉导管相关血栓形成的预防和管理提出的临床指导。

中文标题:

2013 国际临床实践指南:癌症患者中心静脉导管血栓形成的治疗和预防

英文标题:

International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.

发布日期:

2013-01-01

简要介绍:

尽管长期留置中心静脉导管可能会导致肺栓塞,临床缺少癌症患者和异质性人群中心静脉导管相关血栓形成的管理共识,本文的主要目的就是针对该类患者中心静脉导管相关血栓形成的预防和管理提出的临床指导。

拓展指南:血栓形成相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2013 国际临床实践指南:癌症患者中心静脉导管血栓形成的治疗和预防)] GetToolGuiderByIdResponse(projectId=1, id=9382f1c001310af6, title=2013 国际临床实践指南:癌症患者中心静脉导管血栓形成的治疗和预防, enTitle=International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer., guiderFrom=J Thromb Haemost. 2013 Jan;11(1):71-80., authorId=null, author=, summary=尽管长期留置中心静脉导管可能会导致肺栓塞,临床缺少癌症患者和异质性人群中心静脉导管相关血栓形成的管理共识,本文的主要目的就是针对该类患者中心静脉导管相关血栓形成的预防和管理提出的临床指导。, cover=, journalId=null, articlesId=null, associationId=1314, associationName=国际血栓形成和癌症创议, associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 01 00:00:00 CST 2013, originalUrl=, linkOutUrl=, content=尽管长期留置中心静脉导管可能会导致肺栓塞,临床缺少癌症患者和异质性人群中心静脉导管相关血栓形成的管理共识,本文的主要目的就是针对该类患者中心静脉导管相关血栓形成的预防和管理提出的临床指导。<br> <br> 拓展指南:<strong>与<font color="red">血栓形成</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=9382f1c001310af6" title="2016 国际临床实践指南:癌症患者中心静脉导管血栓形成的治疗和预防" target="_blank">2016 国际临床实践指南:癌症患者中心静脉导管血栓形成的治疗和预防</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0b19b1c00129992c" title="2016 KSVS实践指南:下肢深静脉血栓形成的诊断和治疗" target="_blank">2016 KSVS实践指南:下肢深静脉血栓形成的诊断和治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3508b1c001292901" title="2016 中国脑静脉系血栓形成指导规范" target="_blank">2016 中国脑静脉系血栓形成指导规范</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=dbffb1c0012a08d7" title="2012 ACCP抗栓治疗和血栓形成预防临床实践指南(第9版)" target="_blank">2012 ACCP抗栓治疗和血栓形成预防临床实践指南(第9版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4c9b21c0012192a1" title="2015 ASGE指南:胃肠道内窥镜检查患者抗血栓形成药物的管理" target="_blank">2015 ASGE指南:胃肠道内窥镜检查患者抗血栓形成药物的管理</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E6%A0%93%E5%BD%A2%E6%88%90" target="_blank">有关血栓形成更多指南</a></ul>, tagList=[TagDto(tagId=7009, tagName=血栓形成), TagDto(tagId=2813, tagName=癌症患者), TagDto(tagId=2387, tagName=中心静脉导管)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5404, appHits=248, showAppHits=1, pcHits=3538, showPcHits=2440, likes=159, shares=7, comments=3, approvalStatus=1, publishedTime=Wed Oct 19 10:51:02 CST 2016, publishedTimeString=2013-01-01, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Wed Oct 19 10:51:02 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:31:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2013 国际临床实践指南:癌症患者中心静脉导管血栓形成的治疗和预防)])
2013 国际临床实践指南:癌症患者中心静脉导管血栓形成的治疗和预防
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1062004, encodeId=def2106200472, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 17:05:39 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062002, encodeId=7197106200273, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 17:05:13 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051918, encodeId=e1dc105191810, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 12:08:08 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-10-19 湘雅科教

    非常好的文章,受益匪浅。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1062004, encodeId=def2106200472, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 17:05:39 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062002, encodeId=7197106200273, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 17:05:13 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051918, encodeId=e1dc105191810, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 12:08:08 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-10-19 湘雅科教

    非常好的文章,受益匪浅。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1062004, encodeId=def2106200472, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 17:05:39 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062002, encodeId=7197106200273, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 17:05:13 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051918, encodeId=e1dc105191810, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 12:08:08 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    受益匪浅

    0